Joseph J. Larosa - 24 Jun 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Issuer symbol
REGN
Transactions as of
24 Jun 2024
Net transactions value
-$3,721,049
Form type
4
Filing time
25 Jun 2024, 16:39:50 UTC
Previous filing
12 Jun 2024
Next filing
12 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $8,029,432 +14,450 +40% $555.67 50,887 24 Jun 2024 Direct
transaction REGN Common Stock Tax liability $11,750,481 -11,084 -22% $1060.13 39,803 24 Jun 2024 Direct
holding REGN Common Stock 371 24 Jun 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -14,450 -50% $0.000000 14,450 24 Jun 2024 Common Stock 14,450 $555.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.